Mining millets
Millets are ancient grains and cereals with origins in Africa, the Middle East and Asian countries including China and India, where they are food staples. In addition to growing in harsh environments and enduring drought or attacks by pests, millets are often less processed and yield higher nutritional benefits than grains such as corn, rice and wheat.
Those conventional grains of the Western diet are well studied, but scientists know little about the bioactive food species in major and minor millets, including the distribution of lipids, or fat-soluble compounds; the composition of fatty acids, or lipid building blocks; and the presence of nutraceuticals, or substances in millets and food that benefit physiological health.
Sugasini Dhavamani, a research assistant professor at the University of Illinois at Chicago, and her team have studied the nutri-lipidomic profiles of major and minor millet seeds and oils.
“I am passionate about lipid research,” Dhavamani said, “I love working at the University of Illinois because we have amazing equipment and facilities, and great means for collaboration.”
The oils of grains are not commercially available, so the researchers first extracted lipids from the millets, then analyzed samples using high-performance liquid chromatography and gas chromatography-mass spectrometry.
“The oil extraction takes time,” Dhavamani said, adding that the researchers face other challenges. “After extraction we often get a low quantity of lipids, which can also cause difficulty. Stability is a concern because the lipids are easily oxidized.”
After profiling sorghum millet, little millet, finger millet, proso millet, kodo millet, pearl millet and foxtail millet, Dhavamani and colleagues found that oleic acid, linoleic acid and alpha-linoleic acid, or omega-9,-6 and -3, are the three major fatty acid species present in millets and seed oils.
“Most of the millets evaluated contained omega-9 and omega-6 and a small amount of omega-3 fatty acids, which help to lower cholesterol and blood pressure levels, and can benefit chronic disease,” Dhavamani said. “Millets also have nutraceuticals, which are helpful for lowering inflammation.”
In the future, the researchers want to expand this work into animal models, where Dhavamani can assess the health benefits of millet consumption, followed by examining proteomics and metabolomics of millets; however, experiments of this scale require increased funding.
Details
Sugasini Dhavamani will present this research from 5:30 to 6:30 p.m. CDT on Sunday, March 24, at Discover BMB 2024, the American Society for Biochemistry and Molecular Biology annual meeting in San Antonio. Her poster will be at board 326.
Abstract title: Nutri-lipidomics, bioactive lipids and antioxidant potential of major and minor millet seed and oil — a novel approach
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.